
September 2, 2004 |
2004-R-0619 | |
STATE BIOSCIENCE ECONOMIC DEVELOPMENT PROGRAMS | ||
| ||
By: John Rappa, Principal Analyst | ||
You asked how California, Connecticut, Massachusetts, New Jersey, and New York promote the bioscience industry and recruit bioscience firms. You specifically wanted to know how much money and staff each of these states allocate for these activities and the incentives they offer to bioscience firms.
SUMMARY
The five states promote the bioscience industry in similar ways. They rely on private trade associations to assess and communicate the industry’s needs, inform the public about how the industry benefits the state, and provide technical assistance to their members.
We could not obtain data on the resources the states commit toward attracting and recruiting bioscience firms. States generally do not disclose how they identify and contact the firms they want to attract, a national biotechnology trade association spokesman stated. These initiatives usually involved high level, confidential discussions between a state’s top officials and a firm’s CEO. The National Association of State Economic Development Agencies (NASDA) tracks how much its member agencies spend on advertising, but not for bioscience or other specified purposes, Miles Freedman, NASDA’s executive director, stated.
Nor does it appear that state agencies fund national advertising campaigns designed exclusively to attract bioscience firms. Instead, they market their products and services to a broader business audience. All maintain web pages describing the states’ incentives and providing links to other public and private agencies offering different types of financial and technical assistance. The New Jersey Commerce and Economic Growth Commission’s Business Attraction and Development Department provides one-stop shopping for out-of-state businesses interested in moving to New Jersey. (The nonprofit Connecticut Economic Resource Center provides a similar service here. )
The states offer bioscience firms largely the same incentives they offer to other high technology firms. They also stimulate new research by funding new facilities, university-business research partnerships, and bioscience career programs.
But a recent report about the challenges facing California’s bioscience firms could also apply to other states:
As this two-decades old industry matures, with more and more products in advanced clinical trials, it is moving beyond a primarily R&D based industry, adding manufacturing to its repertoire. Now, as a manufacturing industry, it faces significant new challenges and risks in California: a record state budget deficit, deteriorating infrastructure, legal and regulatory burdens that deter business expansion and job creation, and a global market where other countries and dozens of American states are competing to attract new plants and facilities (California’s Biomedical Industry: 2004 Report, PriceWaterhouseCoopers).
PROMOTING BIOSCIENCE
The five states rely mainly on private bioscience trade associations to promote the industry, a practice common in most states. They rely on the associations to “coordinate the needs of … corporate members and to provide a more-or-less unified voice to which government offices can respond” (Blakely and Nishikawa, “Incubating High technology Firms: State Economic Development Strategies for Biotechnology,” Economic Development Quarterly, August 1992).
For example, the Massachusetts Biotechnology Council keeps the government and the public informed about new research and its economic potential, comments on legislation affecting the industry, and supports political candidates who support its views. California’s BioBay analyzes industry trends, represents the industry’s interests before state and federal policy makers, helps its members collaborate on different projects, runs a cost-saving group purchasing program, and advises entrepreneurs about starting new businesses.
Table 1 compares the state agencies and private organizations that promote bioscience. The latter includes organizations that promote bioscience along with other high technology industries. As the Table 1 shows, Connecticut and New Jersey are the only states that devote staff resources exclusively to bioscience, but their tasks are limited to helping firms obtain state assistance and, in Connecticut’s case, secure licenses and permits.
Table 1: Selected States’ Organizations with Bioscience Promotion Responsibilities
|
State |
State Agency |
Private Organization | ||
|
Bioscience |
Economic Development |
Bioscience Trade Association |
High Technology Organization | |
CA |
No |
California Business, Transportation, and Housing Agency, Commerce & Economic Development Program |
• BioBay (San Francisco) • BIOCOM (San Diego) • Southern California Biomedical Council |
California Council on Science and Technology |
CT |
Biotechnology Office, Department of Economic and Community Development |
Connecticut Innovations, Inc. |
Connecticut United for Research Excellence |
Connecticut Technology Council |
MA |
No |
• Mass Development, • Massachusetts Technology Development Corporation • Massachusetts Technology Collaborative |
• Massachusetts Biotechnology Council • Massachusetts Medical Device Industry Council • Life Science Coordinating Group • Bioeconomic Technology Alliance |
Enterprise Forum |
NJ |
Bioscience contact in newly reorganized Commerce and Economic Growth Commission |
• Commission on Jobs, Growth, and Economic Competitiveness • New Jersey Economic Development Authority • New Jersey Commerce and Economic Growth Commission |
• Biotechnology Council of New Jersey • New Jersey Biotechnology and Life Science Coalition • Healthcare Institute of New Jersey • New Jersey Life Science |
• Technology Council of New Jersey • R&D Council of New Jersey • Prosperity New Jersey |
NY |
No |
• New York State Office of Science, Technology and Academic Research Office for Technology • Empire State Development Corporation |
New York Biotechnology Association |
Many regionally based technology development associations |
RECRUITING BIOSCIENCE FIRMS
State officials keep their strategies for recruiting bioscience firms close to their vest, opined Patrick Kelly, the Biotechnology Industry Organization’s Government Relations Officer. Kelly knew of no studies comparing state recruitment programs, and we could find none either.
None of the five states we studied appear to run advertising campaigns designed exclusively to lure bioscience firms. Most state high technology agencies are reluctant to fund costly national advertising campaigns, Jim Denn, the New York State Office of Science, Technology and Academic Research (NYSTAR) stated. NYSTAR allocates no funds for national advertising campaigns targeting bioscience or other types of high technology firms. Instead, it markets its products and services to a broad business audience through web sites, brochures, newsletters, and other printed materials.
Other states take a similar approach, using web sites and brochures to highlight the state’s low business taxes, skilled workforce, good roads, financial incentives, and other factors that make the state a good place to run a business. The New Jersey Economic Development Authority (NJEDA) uses the web to advertise its products and services, but also relies on private trade associations to promote the state and its programs, NJEDA official Glenn Phillips explained. Its senior officials personally reinforce the message by serving on the associations’ boards.
State and privately funded bioscience research centers indirectly attract bioscience firms when they publicize their research successes, Denn explained. Bioscience and other types of high technology firms seem to locate near major university research centers where business and university researchers can share ideas and facilities.
DIRECT ASSISTANCE
Bioscience Business Incentives
As Table 2 shows, the states offer bioscience firms similar types of incentives, including technical assistance, venture capital, and R&D tax credits. They also provide low rent space and business support services for early stage bioscience firms (i. e. , incubators). But few, such as CII’s Bioscience Facilities Fund, target these incentives exclusively at bioscience firms.
Table 2: Selected States Incentives for Bioscience Firms
|
State |
Technical Assistance |
Financing |
Venture Capital |
Tax Incentives |
Bioscience Incubators |
CA |
Available from state-funded Nonprofit Regional Technology Alliances |
Industrial revenue bond financing available from Commerce and Economic Development Program |
State pension fund earmarks funds for bioscience venture capital investments |
No |
Three |
CT |
Available from nonstate sources (e. g. , federally funded Small Business Development Centers) |
Different types of loans and loan guarantees available from DECD and the Connecticut Development Authority; laboratory construction financing available from CII |
Available from CII |
Bioscience firms eligible for generic property tax exemptions and refundable research and development corporate business tax credits |
Bioscience incubators at Yale’s Science Park and UConn’s Bioscience Complex and Health Care Center |
MA |
Entrepreneurial assistance available for Massachusetts Institute for Technology’s Enterprise Forum |
Building and bridge loans available from MassDevelopment and Massachusetts Technology Development Corporation (MTDC), respectively |
Available from the quasi-public MTDC |
Bioscience firms qualify for standard investment tax credit |
Three |
NJ |
State’s Small Business Development Centers target technology firms |
NJEDA working capital seed loans and working capital and fixed asset loans available for early and second stage companies, respectively |
NJEDA grants available for early stage companies and private venture capital available from private funds where the state is a limited partner NJEDA mentoring program matches private investors with early stage companies |
Transferable R&D business tax credits |
Three |
NY |
Business development assistance available from NYSTAR-funded regional technology development centers |
Grants available for constructing facilities in state-designated Empire Zones |
Bioscience firms qualify for New York State Common Retirement Fund and Certified Capital Company investments Seed funding available from Empire State’s Small Business Technology Fund |
People and businesses qualify for a 10% credit for investing in qualified emerging technology companies |
52 |
Source: Laboratories of Innovation: State Bioscience Initiatives 2004, Battelle Technology Partnership Practice and SSTI, June 2004
Bioscience Strategic Investments
Besides offering incentives to individual bioscience firms, the states invest in the infrastructure needed to stimulate and sustain the industry’s development. As Table 3 shows, the states fund new research facilities, establish academic degree and certificate programs addressing the sector’s workforce needs, and encourage professors and business researchers to collaborate on research that could result in new products or techniques. Private developers have developed research parks in California and Massachusetts, while state agencies or universities have done so in the other states.
Table 3: Bioscience Strategic Investments
|
State |
ResearchFacilities |
Cooperative Research |
Research Parks |
Commercial Applications |
Workforce |
CA |
Two bioscience research institutes received $ 100 million in matching state grants |
University of California provides grants to professors who work with businesses on research projects |
Privately developed research parks located near several major universities |
UC San Diego funds translational medicine research with commercial potential |
UC funds biotechnology curriculum development, multidisciplinary research and training, and joint ventures with businesses |
CT |
CII finances private research laboratories |
CII funds university-business collaborative research with commercial potential |
State invested $ 14 million in Yale’s Science Park |
UConn Center for Science and Technology Commercialization advises and assists faculty and students about marketing inventions and discoveries |
Efforts to encourage high school students to pursue biotech careers include mobile laboratory, teaching materials, and science and technology scholarships |
MA |
Umass Amherst’s and Bay State Medical Center’s Biomedical Research Institute developed with $ 90 million appropriation |
In 2003, $ 15 million appropriate for academic research centers to match federal funds and $ 20 million appropriated for collaborative research in several bioscience fields |
At least four privately owned bioscience research parks |
In 2003, $ 2. 4 million appropriated for new technology transfer center at UMass (MIT and BU also fund technology transfers) |
Harvard and MIT have recently added bioscience curricula |
-Continued-
|
State |
ResearchFacilities |
Cooperative Research |
Research Parks |
Commercial Applications |
Workforce |
NJ |
International Center for Public Health recently developed with $ 15 million appropriation and $ 46 million in revenue bond proceeds Bioscience research centers developed at Rutgers, UMDNJ, and Princeton |
No information |
NJEDA funded North Burnswick New Jersey Technology Center hosts three life science firms Newark’s University Heights Science Park developed by a university |
No information |
Rutgers and Robert Wood Johnson Medical School offer graduate degrees in bioscience fields. |
NY |
Buffalo’s proposed bioinformatics center will receive Empire State Development Corporation matching funds SUNY funded life science building at Albany campus NYSTAR funded five bioscience related research centers |
NYSTAR funds university-business research partnerships in bioscience and other fields |
Three university supported bioscience research parks being planned |
NYSTAR funded Science and Technology Law Center at Syracuse University provides legal advise to entrepreneurs and university technology transfer offices |
SUNY Buffalo MBA program offers biotechnology management option Certificates in biotechnology and bioscience industry fundamentals available at SUNY’s Hunter College and Stony Brook, respectively |
Source: Laboratories of Innovation: State Bioscience Initiatives 2004, Battelle Technology Partnership Practice and SSTI, June 2004
JR: ts